The FDA is nearing a move to allow people to get a Covid-19 booster that's different from their initial vaccine, people familiar with the matter say on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ4 years ago
Biden administration officials told states that the U.S. will reallocate Covid-19 vaccine doses that go unordered to states that are in need of additional shots, a person familiar with the matter said on.wsj.com
@WSJ4 years ago
United Airlines began charter flights to position Pfizer’s Covid-19 vaccine for distribution if the shots are approved, people familiar with the matter said on.wsj.com
@WSJ3 years ago
The FDA is nearing a move to allow people to get a Covid-19 booster that's different from their initial vaccine, people familiar with the matter say on.wsj.com
@WSJ4 years ago
The FDA expects to have a strategy on Covid-19 vaccine boosters by early September that would lay out when and which individuals should get the follow-up shots, according to people familiar with discussions of the matter on.wsj.com
@WSJ4 years ago
The FDA is investigating what caused a batch of the active ingredient for J&J’s Covid-19 vaccine to be scrapped, a person familiar with the matter said. on.wsj.com
@WSJ4 years ago
Covid-19 vaccine trial from AstraZeneca and the University of Oxford can resume in U.S., according to a person familiar with the matter on.wsj.com
@WSJ3 years ago
Breaking: The FDA has delayed a decision on clearing Moderna's Covid-19 vaccine for 12-to-17-year-olds while it looks into the risk of the rare heart condition myocarditis, people familiar with the matter say on.wsj.com
@WSJ4 years ago
The Food and Drug Administration has raised the minimum number of young children that should be in Covid-19 vaccine trials to better detect any side effects, people familiar with the matter said on.wsj.com
@WSJ4 years ago
The U.S. authorized Johnson & Johnson's one-shot Covid-19 vaccine, people familiar with the matter said. The company expects to ship four million doses right away. on.wsj.com
@WSJ4 years ago
U.S. health regulators drafted guidelines that would set rigorous standards and make it difficult for a Covid-19 vaccine to be authorized for emergency use before Election Day, people familiar with the matter said on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ4 years ago
The WHO says it still needs answers from Covid-19 vaccine maker Sinovac, people familiar with the matter say on.wsj.com
@WSJ4 years ago
Mark Machin, head of Canada’s largest pension fund, got a Covid-19 vaccine shot in the Middle East, according to people familiar with the matter, ahead of millions of Canadians waiting on one of the Western world’s slowest rollouts on.wsj.com
@WSJ4 years ago
A federal vaccine advisory committee will put off a vote on recommending who should get initial limited doses of any Covid-19 vaccine in the U.S., until committee members learn more, according to people familiar with the matter on.wsj.com